STAAR Surgical Company (STAA)

Return on total capital

Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020
Earnings before interest and tax (EBIT) (ttm) US$ in thousands -12,611 25,704 24,937 20,149 24,071 14,964 23,754 32,627 43,099 48,778 42,910 37,576 32,933 30,033 27,078 15,374 6,612 4,877 3,329 8,225
Long-term debt US$ in thousands
Total stockholders’ equity US$ in thousands 397 428,122 409,103 392,788 385,954 378,595 353,697 338,924 336,112 320,132 299,307 276,317 258,558 249,108 234,622 214,176 197,222 186,392 174,674 164,967
Return on total capital -3,176.57% 6.00% 6.10% 5.13% 6.24% 3.95% 6.72% 9.63% 12.82% 15.24% 14.34% 13.60% 12.74% 12.06% 11.54% 7.18% 3.35% 2.62% 1.91% 4.99%

December 31, 2024 calculation

Return on total capital = EBIT (ttm) ÷ (Long-term debt + Total stockholders’ equity)
= $-12,611K ÷ ($—K + $397K)
= -3,176.57%

STAAR Surgical Company's return on total capital has fluctuated over the past few years, starting at 4.99% in March 2020 and reaching a peak of 15.24% in September 2022. However, there was a significant negative anomaly in December 2024, with a -3,176.57% return on total capital. This extreme value may be attributed to exceptional circumstances or accounting irregularities.

Overall, STAAR Surgical Company has shown varying levels of return on total capital, demonstrating both growth and volatility in the company's capital efficiency. It is important for stakeholders to monitor these fluctuations and understand the factors influencing such drastic changes in performance.


Peer comparison

Dec 31, 2024

Company name
Symbol
Return on total capital
STAAR Surgical Company
STAA
-3,176.57%
National Vision Holdings Inc
EYE
-0.92%
The Cooper Companies, Inc. Common Stock
COO
6.58%